Perkins Coie Trust Company’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $9.77M | Sell |
8,149
-14
| -0.2% | -$14.3K | 1.62% | 18 |
|
|
2026
Q1 | $7.51M | Buy |
8,163
+185
| +2% | +$188K | 1.44% | 18 |
|
|
2025
Q4 | $8.57M | Buy |
7,978
+279
| +4% | +$267K | 1.6% | 16 |
|
|
2025
Q3 | $5.87M | Buy |
7,699
+1,066
| +16% | +$793K | 1.11% | 26 |
|
|
2025
Q2 | $5.17M | Buy |
6,633
+62
| +0.9% | +$48.2K | 0.88% | 30 |
|
|
2025
Q1 | $5.43M | Buy |
6,571
+521
| +9% | +$434K | 1.23% | 23 |
|
|
2024
Q4 | $4.67M | Buy |
6,050
+136
| +2% | +$113K | 1.03% | 31 |
|
|
2024
Q3 | $5.24M | Buy |
5,914
+156
| +3% | +$140K | 1.16% | 26 |
|
|
2024
Q2 | $5.21M | Buy |
5,758
+1,313
| +30% | +$1.05M | 1.21% | 23 |
|
|
2024
Q1 | $3.46M | Buy |
4,445
+571
| +15% | +$406K | 0.81% | 42 |
|
|
2023
Q4 | $2.26M | Buy |
3,874
+3,390
| +700% | +$1.98M | 0.57% | 52 |
|
|
2023
Q3 | $260K | Buy |
484
+30
| +7% | +$15.5K | 0.07% | 89 |
|
|
2023
Q2 | $213K | Hold |
454
| – | – | 0.06% | 83 |
|
|
2023
Q1 | $156K | Hold |
454
| – | – | 0.05% | 91 |
|
|
2022
Q4 | $166K | Hold |
454
| – | – | 0.05% | 88 |
|
|
2022
Q3 | $147K | Hold |
454
| – | – | 0.06% | 91 |
|
|
2022
Q2 | $147K | Hold |
454
| – | – | 0.05% | 89 |
|
|
2022
Q1 | $130K | Hold |
454
| – | – | 0.04% | 95 |
|
|
2021
Q4 | $125K | Hold |
454
| – | – | 0.04% | 94 |
|
|
2021
Q3 | $105K | Sell |
454
-284
| -38% | -$70.1K | 0.03% | 109 |
|
|
2021
Q2 | $169K | Sell |
738
-191
| -21% | -$38.4K | 0.05% | 96 |
|
|
2021
Q1 | $174K | Sell |
929
-320
| -26% | -$62.6K | 0.06% | 97 |
|
|
2020
Q4 | $211K | Sell |
1,249
-369
| -23% | -$55.1K | 0.07% | 99 |
|
|
2020
Q3 | $239K | Sell |
1,618
-400
| -20% | -$61.9K | 0.1% | 90 |
|
|
2020
Q2 | $331K | Sell |
2,018
-400
| -17% | -$61.4K | 0.14% | 86 |
|
|
2020
Q1 | $335K | Buy |
2,418
+416
| +21% | +$57.2K | 0.17% | 82 |
|
|
2019
Q4 | $263K | Hold |
2,002
| – | – | 0.11% | 90 |
|
|
2019
Q3 | $224K | Hold |
2,002
| – | – | 0.1% | 91 |
|
|
2019
Q2 | $222K | Buy |
2,002
+400
| +25% | +$47.1K | 0.1% | 91 |
|
|
2019
Q1 | $208K | Hold |
1,602
| – | – | 0.1% | 93 |
|
|
2018
Q4 | $185K | Hold |
1,602
| – | – | 0.1% | 91 |
|
|
2018
Q3 | $172K | Hold |
1,602
| – | – | 0.08% | 101 |
|
|
2018
Q2 | $137K | Hold |
1,602
| – | – | 0.07% | 106 |
|
|
2018
Q1 | $124K | Hold |
1,602
| – | – | 0.06% | 114 |
|
|
2017
Q4 | $135K | Hold |
1,602
| – | – | 0.07% | 107 |
|
|
2017
Q3 | $137K | Hold |
1,602
| – | – | 0.07% | 107 |
|
|
2017
Q2 | $132K | Hold |
1,602
| – | – | 0.07% | 105 |
|
|
2017
Q1 | $135K | Hold |
1,602
| – | – | 0.08% | 90 |
|
|
2016
Q4 | $118K | Hold |
1,602
| – | – | 0.07% | 95 |
|
|
2016
Q3 | $129K | Hold |
1,602
| – | – | 0.08% | 90 |
|
|
2016
Q2 | $126K | Hold |
1,602
| – | – | 0.08% | 89 |
|
|
2016
Q1 | $115K | Hold |
1,602
| – | – | 0.08% | 90 |
|
|
2015
Q4 | $135K | Hold |
1,602
| – | – | 0.1% | 79 |
|
|
2015
Q3 | $134K | Hold |
1,602
| – | – | 0.11% | 77 |
|
|
2015
Q2 | $134K | Buy |
1,602
+801
| +100% | +$61K | 0.1% | 82 |
|
|
2015
Q1 | $58K | Buy |
+801
| New | +$57K | 0.04% | 122 |
|
Other funds holding LLY
SC
ONB
GIM
Perkins Coie Trust Company's LLY Position: Q2 2026 in Review
Perkins Coie Trust Company reduced its Eli Lilly (LLY) stake by 0.17% in Q2 2026, selling an estimated $14.3K and leaving 8,149 shares worth $9.77M. The position accounts for 1.62% of the portfolio, ranked #18.
Perkins Coie Trust Company first reported a position in LLY in Q1 2015 and has held it in 46 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Perkins Coie Trust Company held 8,149 shares of Eli Lilly worth $9.77M as of Q2 2026.
- Perkins Coie Trust Company sold 14 Eli Lilly shares in Q2 2026, an estimated $14.3K.
- Eli Lilly made up 1.62% of Perkins Coie Trust Company's portfolio in Q2 2026, its #18 holding.
- Perkins Coie Trust Company first reported a position in Eli Lilly in Q1 2015 and has held it in 46 quarters since.
- 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Perkins Coie Trust Company's 13F filing for Q2 2026, filed 9 Jul 2026.